£1.5M Round to Scale AI-Powered Diagnostic Platform

We are raising £1.5M to accelerate the clinical and commercial scale-up of our Lab-in-a-Box diagnostics platform.

Use of funds:

• Finalise CE-IVDR and ISO 13485 certification

• Expand our R&D pipeline (oncology & infectious disease panels)

• Onboard senior commercial, regulatory, and operational leaders

• Accelerate go-to-market in the UK and EU

Key partnerships already in place include:

• UK Health Security Agency (UK) – origin of the spin-out and national health security leader

• Oscar Lambret Cancer Center (France) – leading partner in oncology test validation

• Columbia University (USA) – for translational research and AI validation

• Oslo University Hospital (Norway) – clinical collaboration in infectious disease genomics

With over £1M in signed contracts and revenue, we are seeking mission-aligned investors in healthtech, diagnostics, and deeptech to support our scale-up and international certification strategy.